Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ingelsson

Showing results (121-130 of 217) with videos related to

Pageof 22
Sort By:
Dementia and Geriatric Cognitive Disorders|November 27, 2009
No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degenerationLena Skoglund, Sofie Ingvast, Toshifumi Matsui, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Acta Neuropathologica Communications|November 21, 2013
N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibodyGregory Antonios, Nasrin Saiepour, Yvonne Bouter, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Cell Reports|May 12, 2015
Quantitative interaction proteomics of neurodegenerative disease proteinsFabian Hosp, Hannes Vossfeldt, Matthias Heinig, et al.
Neurobiology of Aging|November 29, 2011
The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated AβOla Philipson, Anna Lord, Maciej Lalowski, et al.
Scientific Reports|July 27, 2021
Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99Jonas Mattisson, Marcus Danielsson, Maria Hammond, et al.
Archives of Neurology|February 13, 2008
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort studyJohan Sundelöf, Vilmantas Giedraitis, Michael C Irizarry, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2009
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease casesOliver Wirths, Tobias Bethge, Andrea Marcello, et al.
Brain : a Journal of Neurology|September 8, 2025
Skin intraneural phosphorylated α-synuclein is a highly specific biomarker for early Parkinson's diseaseVincenzo Donadio, Alex Incensi, Giovanni Rizzo, et al.
Pageof 22

Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
Dementia and Geriatric Cognitive Disorders|November 27, 2009
No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degenerationLena Skoglund, Sofie Ingvast, Toshifumi Matsui, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Acta Neuropathologica Communications|November 21, 2013
N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibodyGregory Antonios, Nasrin Saiepour, Yvonne Bouter, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Cell Reports|May 12, 2015
Quantitative interaction proteomics of neurodegenerative disease proteinsFabian Hosp, Hannes Vossfeldt, Matthias Heinig, et al.
Neurobiology of Aging|November 29, 2011
The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated AβOla Philipson, Anna Lord, Maciej Lalowski, et al.
Scientific Reports|July 27, 2021
Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99Jonas Mattisson, Marcus Danielsson, Maria Hammond, et al.
Archives of Neurology|February 13, 2008
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort studyJohan Sundelöf, Vilmantas Giedraitis, Michael C Irizarry, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2009
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease casesOliver Wirths, Tobias Bethge, Andrea Marcello, et al.
Brain : a Journal of Neurology|September 8, 2025
Skin intraneural phosphorylated α-synuclein is a highly specific biomarker for early Parkinson's diseaseVincenzo Donadio, Alex Incensi, Giovanni Rizzo, et al.
Pageof 22